Click here for ratings changes.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Apple ( AAPL) estimates, target increased at UBS. AAPL estimates were raised through 2012, UBS said. Company had strong holiday sales and is carrying a lot of momentum into the new year. Buy rating and new $415 price target.

Albermarle ( ALB) estimates, target upped at Jefferies. ALB estimates were boosted through 2012, Jefferies said. Company should benefit from better pricing. Buy rating and new $75 price target.

American Axle ( AXL) target raised at Credit Suisse to $15 from $13. 2011 guidance slightly ahead of expectations, Credit Suisse said. Maintain Neutral rating.

Bank of America ( BAC) cut from Top Picks Live list at Citigroup. Valuation call, based on an $18 price target.

Bristol-Myers ( BMY) estimates cut at Morgan Stanley through 2012, Morgan Stanley said. Ipi launch is being pushed out. Equal-weight rating and $28 price target.

Cardinal Health ( CAH) numbers raised at UBS. Shares of CAH now seen reaching $47, according to UBS. Estimates also increased, as recent acquisitions should add to growth. Buy rating.

Canadian National Railway ( CNI) price target raised at Barclays to $77 from $68. Another robust year for North American coal exports, Barclays said. Maintain Equal Weight rating.

Canadian Pacific Railway ( CP) price target boosted at Barclays to $77 from $67. Volume end the year on a high note, Barclays said. Maintain Equal Weight rating.

Cognizant ( CTSH) added to Conviction Buy List at Goldman. Offshore growth should continue to drive earnings.

Huntsman ( HUN) estimates, target increased at Jefferies. HUN estimates were raised through 2012, Jefferies said. Company has significant operating leverage. Buy rating and new $21 price target.

Lazard ( LAZ) price target boosted at Credit Suisse. LAZ price target increased to $40 from $37. 2010 finished on strong note, with M&A deal closings exceeding expectations, Credit Suisse said. Maintain Neutral rating. Estimates raised through 2012.

Nasdaq OMX ( NDAQ) cut from Conviction Buy List at Goldman. Relative valuation call, based on a $28 price target.

St. Jude ( STJ) numbers raised at Citigroup. Shares of STJ now seen reaching $39, according to Citigroup. Estimates also increased, to match the company's new guidance. Sell rating.

Terex ( TEX) target, estimates increased at Credit Suisse. TEX shares now seen reaching $44, up from $38. Higher conviction on US recovery, Credit Suisse said. 2011 and 2012 EPS estimates raised to $0.80 and $2.35, respectively. Outperform rating.

Union Pacific ( UNP) price target lifted at Barclays to $110 from $94. Grain exports should boosted earnings, Barclays said. Maintain Equal Weight rating.

Verigy ( VRGY) price target boosted at Citi to $15, up from $9. Inching closer to ATE deal, Citigroup said. Maintain Hold rating.

Verizon ( VZ) estimates, target boosted at Citigroup. Shares of VZ now seen reaching $39, according to Citigroup. Estimates also upped, given lower expected pension dilution. Buy rating.
This article was written by a staff member of TheStreet.

If you liked this article you might like

FDA Official Calls for Ending Codeine Use in Kids Cough Products

Big Drug Makers Could Face More Pressure on Codeine Remedies for Kids

Cramer: Finding the Flaws in Amazon

Cardinal Health: Cramer's Top Takeaways

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)